• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    CHARLES & COLVARD REPORTS THIRD QUARTER FISCAL YEAR 2023 FINANCIAL RESULTS

    5/4/23 4:07:00 PM ET
    $CTHR
    Consumer Specialties
    Consumer Discretionary
    Get the next $CTHR alert in real time by email

    Conference Call with Accompanying Slide Presentation Scheduled Today at 4:30 PM ET

    RESEARCH TRIANGLE PARK, N.C., May 4, 2023 /PRNewswire/ -- Charles & Colvard, Ltd. (NASDAQ:CTHR) (the "Company"), a globally recognized fine jewelry company specializing in lab created Made, Not MinedTM gemstones, reported financial results for the third quarter ended March 31, 2023 ("Third Quarter Fiscal 2023"). 

    (PRNewsfoto/Charles & Colvard, Ltd.)

    Management Commentary 

    "We remain focused on capitalizing on the changing behaviors and dynamics in the fine jewelry market, and we continued to make strategic investments in our direct-to-consumer web properties and video streaming and broadcast capabilities during the third fiscal quarter," said Don O'Connell, President and CEO of Charles & Colvard.

    "While the results of our third quarter largely reflect a continuation of the movement of the last few quarters against the current challenging macroeconomic backdrop,  we believe that we continue to make meaningful progress on our underlying key strategic initiatives, including the diversification of our product offerings, expansion of our branded direct-to-consumer footprint with a focus on finished fine jewelry products, and diligent management of the business, in order to drive long-term value when consumer confidence resumes," O'Connell concluded.

    Financial Summary for Third Quarter Fiscal 2023

    (Quarter Ended March 31, 2023 Compared to Quarter Ended March 31, 2022)

    • Net sales of $6.6 million for the quarter, a decrease of 32% from $9.8 million in the year-ago quarter.
    • In the Online Channels segment, which consists of e-commerce outlets including charlesandcolvard.com, moissaniteoutlet.com, third-party online marketplaces, drop-ship retail and other pure-play, exclusively e-commerce outlets, net sales of $4.6 million, a decrease of 27% from the year-ago quarter, representing 70% of total net sales for the quarter, compared to $6.4 million, or 65% of total net sales in the year-ago quarter.
    • In the Traditional segment, which consists of wholesale and retail customers, net sales of $2.0 million, a decrease of 40% from the year-ago quarter, representing 30% of total net sales for the quarter, compared to $3.4 million, or 35% of total net sales, in the year-ago quarter.
    • Finished jewelry net sales of $5.3 million, a decrease of 28% for the quarter, compared to $7.4 million in the year-ago quarter.
    • Loose jewel net sales decreased 43% to $1.3 million for the quarter, compared to $2.3 million in the year-ago quarter.
    • Operating expenses increased 7% to $4.3 million for the quarter, compared to $4.0 million in the year-ago quarter, primarily due to increased investment in marketing strategies.
    • Income tax expense increased to $6.3 million for the quarter, compared to an income tax expense of $78,000 in the year-ago quarter, driven by the establishment of a deferred tax asset valuation allowance on the Company's deferred tax assets.
    • Net loss was $8.4 million, or $0.28 loss per diluted share for the quarter, compared to net income of $0.3 million, or $0.01 earnings per diluted share, in the year-ago quarter.
    • Weighted average diluted shares outstanding were 30.3 million for the quarter, compared to 31.3 million in the year-ago quarter, partially driven by the impact of the effect of the Company's share repurchase program.

    Financial Position

    Cash, cash equivalents and restricted cash totaled $16.0 million as of March 31, 2023, representing a decrease of $1.1 million from $17.0 million as of December 31, 2022, and a decrease of $5.2 million from $21.2 million as of June 30, 2022. Total inventory decreased to $33.3 million as of March 31, 2023, compared to $35.0 million as of December 31, 2022 and $33.5 million as of June 30, 2022. The Company had no debt outstanding as of March 31, 2023.

    Investor Conference Call

    Charles & Colvard will host an investor conference call and webcast presentation to discuss its financial results for the quarter ended March 31, 2023 at 4:30 p.m. ET on Thursday, May 4, 2023. 

    Live Call-In Information: Interested parties can access the conference call by dialing (844) 875-6912 (U.S. toll-free) or (412) 317-6708 (international) and asked to be joined to the Charles & Colvard call.

    Live Webcast Information: Interested parties can access the conference call and accompanying presentation slide via a live webcast, which is available in the Investor Relations section of the Company's website at https://ir.charlesandcolvard.com/events or https://www.webcaster4.com/Webcast/Page/346/47291.  

    A replay of this conference call will be available until May 11, 2023 at (877) 344-7529 (U.S. toll-free) or (412) 317-0088 (international). The replay conference code is 3961523. A webcast replay will be available in the Investor Relations section of the Company's website at https://ir.charlesandcolvard.com/events.

    About Charles & Colvard, Ltd.

    Charles & Colvard, Ltd. (NASDAQ:CTHR) believes that fine jewelry should be as ethical as it is exquisite. Charles & Colvard is the original creator of lab grown moissanite (a rare gemstone formed from silicon carbide). The Company brings revolutionary gems and fine jewelry to market by using exclusively Made, Not MinedTM above ground gemstones and a dedication to 100% recycled precious metals. Their Forever One™ moissanite and Caydia® lab grown diamond brands provide exceptional quality, incredible value and a conscious approach to bridal, high fashion, and everyday jewelry. Charles & Colvard was founded in 1995 and is based in North Carolina's Research Triangle Park region. For more information, please visit www.charlesandcolvard.com.

    Forward-Looking Statements

    This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Statements expressing expectations regarding our future and projections relating to our products, sales, revenues, and earnings are typical of such statements and are made under the Private Securities Litigation Reform Act of 1995. These forward-looking statements include, but are not limited to, statements about our plans, objectives, representations, and contentions and are not historical facts and typically are identified by use of terms such as "may," "will," "should," "could," "expect," "intend," "plan," "anticipate," "believe," "estimate," "predict," "continue," and similar words, although some forward-looking statements are expressed differently.

    All forward-looking statements are subject to the risks and uncertainties inherent in predicting the future. You should be aware that although the forward-looking statements included herein represent management's current judgment and expectations, our actual results may differ materially from those projected, stated, or implied in these forward-looking statements as a result of many factors including, but not limited to, (1) our business and our results of operations could be materially adversely affected as a result of general economic and market conditions; (2) our future financial performance depends upon increased consumer acceptance, growth of sales of our products, and operational execution of our strategic initiatives; (3) we face intense competition in the worldwide gemstone and jewelry industry; (4) our information technology, or IT, infrastructure, and our network may be impacted by a cyber-attack or other security incident as a result of the rise of cybersecurity events; (5) constantly evolving privacy regulatory regimes are creating new legal compliance challenges; (6) we are subject to certain risks due to our international operations, distribution channels and vendors; (7) our business and our results of operations could be materially adversely affected as a result of our inability to fulfill orders on a timely basis; (8) we are currently dependent on a limited number of distributor and retail partners in our Traditional segment for the sale of our products; (9) we may experience quality control challenges from time to time that can result in lost revenue and harm to our brands and reputation; (10) seasonality of our business may adversely affect our net sales and operating income; (11) the effects of COVID-19 and other potential future public health crises, epidemics, pandemics or similar events on our business, operating results, and cash flows are uncertain; (12) our operations could be disrupted by natural disasters; (13) sales of moissanite and lab grown diamond jewelry could be dependent upon the pricing of precious metals, which is beyond our control; (14) our current customers may potentially perceive us as a competitor in the finished jewelry business; (15) we depend on a single supplier for substantially all of our silicon carbide, or SiC, crystals, the raw materials we use to produce moissanite jewels; if our supply of high-quality SiC crystals is interrupted, our business may be materially harmed; (16) if the e-commerce opportunity changes dramatically or if e-commerce technology or providers change their models, our results of operations may be adversely affected; (17) governmental regulation and oversight might adversely impact our operations; (18) the execution of our business plans could significantly impact our liquidity; (19) the financial difficulties or insolvency of one or more of our major customers or their lack of willingness and ability to market our products could adversely affect results; (20) negative or inaccurate information on social media could adversely impact our brand and reputation; (21) we rely on assumptions, estimates, and data to calculate certain of our key metrics and real or perceived inaccuracies in such metrics may harm our reputation and negatively affect our business; (22) we may not be able to adequately protect our intellectual property, which could harm the value of our products and brands and adversely affect our business; (23) environmental, social, and governance matters may impact our business, reputation, financial condition, and results of operations; (24) if we fail to evaluate, implement, and integrate strategic acquisition or disposition opportunities successfully, our business may suffer; (25) our failure to maintain compliance with The Nasdaq Stock Market's continued listing requirements could result in the delisting of our common stock; (26) some anti-takeover provisions of our charter documents may delay or prevent a takeover of our Company; and (27) we cannot guarantee that our share repurchase program will be utilized to the full value approved, or that it will enhance long-term stockholder value and repurchases we consummate could increase the volatility of the price of our common stock and could have a negative impact on our available cash balance, in addition to the other risks and uncertainties described in more detail in our filings with the U.S. Securities and Exchange Commission (the "SEC"), including our Annual Report on Form 10-K for the fiscal year ended June 30, 2022 and subsequent reports filed with the SEC. Forward-looking statements speak only as of the date they are made. We undertake no obligation to update or revise such statements to reflect new circumstances or unanticipated events as they occur except as required by the federal securities laws, and you are urged to review and consider disclosures that we make in the reports that we file with the Securities and Exchange Commission, or SEC, that discuss other factors relevant to our business.

     

    - Financial Tables Follow –

     

     

    CHARLES & COLVARD, LTD.

    CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

    (unaudited)





    Three Months Ended March 31,



    Nine Months Ended March 31,



    2023



    2022



    2023



    2022

    Net sales

    $

    6,641,799



    $

    9,751,835



    $

    24,382,003



    $

    33,785,281

    Cost of goods sold



    4,493,125





    5,296,530





    14,650,910





    17,347,026

    Gross profit



    2,148,674





    4,455,305





    9,731,093





    16,438,255

    Operating expenses:























    Sales and marketing



    3,267,436





    2,932,587





    10,715,066





    9,741,774

    General and administrative



    1,053,357





    1,106,850





    3,654,788





    3,880,684

    Total operating expenses



    4,320,793





    4,039,437





    14,369,854





    13,622,458

    (Loss) Income from operations



    (2,172,119)





    415,868





     

    (4,638,761)





    2,815,797

    Other income (expense):























    Interest income



    69,159





    1,120





    168,935





    1,964

    Loss on foreign currency exchange



    -





    -





    -





    (34)

    Total other income (expense), net



    69,159





    1,120





    168,935





    1,930

    (Loss) Income before income taxes



    (2,102,960)





    416,988





    (4,469,826)





    2,817,727

    Income tax expense



    (6,293,048)





    (78,480)





    (5,858,155)





    (484,582)

    Net (loss) income

    $

    (8,396,008)



    $

    338,508



    $

    (10,327,981)



    $

    2,333,145

















































    Net (loss) income per common share:























    Basic

    $

    (0.28)



    $

    0.01



    $

    (0.34)



    $

    0.08



    Diluted

    $

    (0.28)



    $

    0.01



    $

    (0.34)



    $

    0.07





























    Weighted average number of shares used

         in computing net (loss) income per

         common share:

























    Basic



    30,344,954





    30,484,897





    30,387,303





    30,286,195



    Diluted



    30,344,954





    31,268,410





    30,387,303





    31,271,677



























































     

    CHARLES & COLVARD, LTD.

    CONDENSED CONSOLIDATED BALANCE SHEETS





    March 31, 2023

    (unaudited)



     

    June 30, 2022



    ASSETS













    Current assets:













    Cash and cash equivalents

    $

    10,914,584



    $

    15,668,361



    Restricted cash



    5,056,044





    5,510,979



    Accounts receivable, net



    933,553





    2,220,816



    Inventory, net



    7,889,917





    11,024,276



    Note receivable



    -





    250,000



    Prepaid expenses and other assets



    883,814





    1,190,012



    Total current assets



    25,677,912





    35,864,444



    Long-term assets:













    Inventory, net



    25,439,369





    22,488,524



    Property and equipment, net



    2,317,738





    1,901,176



    Intangible assets, net



    301,310





    265,730



    Operating lease right-of-use assets



    2,336,334





    2,787,419



    Deferred income taxes, net



    -





    5,851,904



    Note receivable



    250,000





    -



    Other assets



    50,387





    49,658



    Total long-term assets



    30,695,138





    33,344,411



    TOTAL ASSETS

    $

    56,373,050



    $

    69,208,855

















    LIABILITIES AND SHAREHOLDERS' EQUITY













    Current liabilities:













    Accounts payable

    $

    3,116,810



    $

    4,401,229



    Operating lease liabilities, current portion



    874,177





    856,571



    Accrued expenses and other liabilities



    1,143,192





    1,546,483



    Total current liabilities



    5,134,179





    6,804,283



    Long-term liabilities:













    Noncurrent operating lease liabilities



    2,251,581





    2,846,805



    Total long-term liabilities



    2,251,581





    2,846,805



    Total liabilities



    7,385,760





    9,651,088

















    Shareholders' equity:













    Common stock, no par value; 50,000,000 shares authorized;

         30,912,108 shares issued and 30,523,705 shares

         outstanding at March 31, 2023 and 30,778,046 shares

         issued and 30,747,759 shares outstanding at June 30,

         2022



    57,242,211





    57,242,211



    Additional paid-in capital



    26,165,810





    25,956,491



    Treasury stock, at cost, 388,403 shares and 30,287 shares

         at March 31, 2023 and June 30, 2022, respectively



    (489,979)





    (38,164)



    Accumulated deficit



    (33,930,752)





    (23,602,771)



    Total shareholders' equity



    48,987,290





    59,557,767



    TOTAL LIABILITIES AND SHAREHOLDERS' EQUITY

    $

    56,373,050



    $

    69,208,855



     

    CHARLES & COLVARD, LTD.

    CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

    (unaudited)





    Nine Months Ended March 31,





    2023

    2022



    CASH FLOWS FROM OPERATING ACTIVITIES:











    Net (loss) income

    $

    (10,327,981)

    $

    2,333,145



    Adjustments to reconcile net (loss) income to net cash (used in) provided by operating activities:











    Depreciation and amortization



    477,285



    350,198



    Stock-based compensation



    209,319



    676,934



    (Recovery of) Provision for uncollectible accounts



    (18,000)



    26,000



    Provision for (Recovery of) sales returns



    59,000



    (25,000)



    Inventory write-downs



    119,000



    232,000



    Provision for accounts receivable discounts



    42



    3,269



    Deferred income taxes



    5,851,904



    483,168



    Changes in operating assets and liabilities:











    Accounts receivable



    1,246,221



    92,264



    Inventory



    64,514



    (3,562,704)



    Prepaid expenses and other assets, net



    756,554



    640,843



    Accounts payable



    (1,284,419)



    356,311



    Accrued income taxes



    -



    1,414



    Accrued expenses and other liabilities



    (980,909)



    (504,862)



           Net cash (used in) provided by operating activities



    (3,827,470)



    1,102,980















    CASH FLOWS FROM INVESTING ACTIVITIES:











    Purchases of property and equipment



    (884,030)



    (1,250,296)



    Payments for intangible assets



    (45,397)



    (38,867)



                  Net cash used in investing activities



    (929,427)



    (1,289,163)















    CASH FLOWS FROM FINANCING ACTIVITIES:











    Repurchases of common stock



    (451,815)



    -



    Stock option exercises



    -



    650,917



                  Net cash (used in) provided by financing activities



    (451,815)



    650,917















    NET (DECREASE) INCREASE IN CASH, CASH EQUIVALENTS, AND RESTRICTED CASH



    (5,208,712)



    464,734



    CASH, CASH EQUIVALENTS, AND RESTRICTED CASH, BEGINNING OF PERIOD



    21,179,340



    21,446,951



    CASH, CASH EQUIVALENTS, AND RESTRICTED CASH, END OF PERIOD

    $

    15,970,628

    $

    21,911,685













    Supplemental disclosure of cash flow information:









           Cash paid during the period for income taxes



    $

    5,900

    $

    -

























    Reconciliation to Condensed Consolidated Balance Sheets:



    March 31,

    2023

    March 31,

    2022

           Cash and cash equivalents



    $

    10,914,584

    $

    16,861,685

           Restricted cash





    5,056,044



    5,050,000

                CASH, CASH EQUIVALENTS, AND RESTRICTED CASH



    $

    15,970,628

    $

    21,911,685



     

    Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/charles--colvard-reports-third-quarter-fiscal-year-2023-financial-results-301816477.html

    SOURCE Charles & Colvard, Ltd.

    Get the next $CTHR alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $CTHR

    DatePrice TargetRatingAnalyst
    9/3/2021$3.50 → $3.75Buy
    Roth Capital
    More analyst ratings

    $CTHR
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Roth Capital reiterated coverage on Charles & Colvard with a new price target

      Roth Capital reiterated coverage of Charles & Colvard with a rating of Buy and set a new price target of $3.75 from $3.50 previously

      9/3/21 8:46:46 AM ET
      $CTHR
      Consumer Specialties
      Consumer Discretionary

    $CTHR
    Financials

    Live finance-specific insights

    See more
    • CHARLES & COLVARD REPORTS THIRD QUARTER FISCAL YEAR 2024 FINANCIAL RESULTS

      Conference Call with Accompanying Slide Presentation Scheduled Today at 4:30 PM ET RESEARCH TRIANGLE PARK, N.C., May 2, 2024 /PRNewswire/ -- Charles & Colvard, Ltd. (NASDAQ:CTHR) (the "Company"), a globally recognized fine jewelry company that specializes in moissanite and lab grown diamonds, reported financial results for the third quarter ended March 31, 2024 ("Third Quarter Fiscal 2024").  Management Commentary  "We remain committed to growth despite a challenging third quarter. We believe our strategic initiatives, continued investments in innovative technology, and dedica

      5/2/24 4:07:00 PM ET
      $CTHR
      Consumer Specialties
      Consumer Discretionary
    • CHARLES & COLVARD TO HOST THIRD QUARTER FISCAL YEAR 2024 INVESTOR CONFERENCE CALL ON MAY 2, 2024 AT 4:30 PM ET

      RESEARCH TRIANGLE PARK, N.C., April 23, 2024 /PRNewswire/ -- Charles & Colvard, Ltd. (NASDAQ:CTHR) (the "Company"), a globally recognized fine jewelry company that specializes in moissanite and lab grown diamonds, will host an investor conference call and webcast presentation to discuss its financial results for the third quarter ended March 31, 2024 ("Third Quarter Fiscal Year 2024") at 4:30 p.m. ET on Thursday, May 2, 2024. The Company will release its financial results after market close on the same day. Third Quarter Fiscal Year 2024 Conference Call DetailsDate and Time: T

      4/23/24 4:08:00 PM ET
      $CTHR
      Consumer Specialties
      Consumer Discretionary
    • CHARLES & COLVARD REPORTS SECOND QUARTER FISCAL YEAR 2024 FINANCIAL RESULTS

      Conference Call with Accompanying Slide Presentation Scheduled Today at 4:30 PM ET RESEARCH TRIANGLE PARK, N.C., Feb. 13, 2024 /PRNewswire/ -- Charles & Colvard, Ltd. (NASDAQ:CTHR) (the "Company"), a globally recognized fine jewelry company that specializes in moissanite and lab grown diamonds, reported financial results for the second quarter ended December 31, 2023 ("Second Quarter Fiscal 2024").  Management Commentary  "We acknowledge the recent industry shift has presented us with numerous challenges and has significantly impacted our earnings. However, we do not believe t

      2/13/24 4:07:00 PM ET
      $CTHR
      Consumer Specialties
      Consumer Discretionary

    $CTHR
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • SEC Form SC 13D/A filed by Charles & Colvard Ltd (Amendment)

      SC 13D/A - CHARLES & COLVARD LTD (0001015155) (Subject)

      2/26/24 7:00:57 PM ET
      $CTHR
      Consumer Specialties
      Consumer Discretionary
    • SEC Form SC 13G/A filed by Charles & Colvard Ltd (Amendment)

      SC 13G/A - CHARLES & COLVARD LTD (0001015155) (Subject)

      2/14/24 9:00:30 AM ET
      $CTHR
      Consumer Specialties
      Consumer Discretionary
    • SEC Form SC 13D/A filed by Charles & Colvard Ltd (Amendment)

      SC 13D/A - CHARLES & COLVARD LTD (0001015155) (Subject)

      11/20/23 4:15:12 PM ET
      $CTHR
      Consumer Specialties
      Consumer Discretionary

    $CTHR
    SEC Filings

    See more
    • SEC Form SD filed by Charles & Colvard Ltd

      SD - CHARLES & COLVARD LTD (0001015155) (Filer)

      6/2/25 5:24:13 PM ET
      $CTHR
      Consumer Specialties
      Consumer Discretionary
    • SEC Form NT 10-Q filed by Charles & Colvard Ltd

      NT 10-Q - CHARLES & COLVARD LTD (0001015155) (Filer)

      5/16/25 5:06:09 PM ET
      $CTHR
      Consumer Specialties
      Consumer Discretionary
    • Charles & Colvard Ltd filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Regulation FD Disclosure, Financial Statements and Exhibits

      8-K - CHARLES & COLVARD LTD (0001015155) (Filer)

      4/22/25 5:02:42 PM ET
      $CTHR
      Consumer Specialties
      Consumer Discretionary

    $CTHR
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • O'Connell Don bought $5,550 worth of shares (15,000 units at $0.37) (SEC Form 4)

      4 - CHARLES & COLVARD LTD (0001015155) (Issuer)

      3/7/24 4:15:57 PM ET
      $CTHR
      Consumer Specialties
      Consumer Discretionary
    • Sykes Ollin B bought $7,028 worth of shares (19,000 units at $0.37) (SEC Form 4)

      4 - CHARLES & COLVARD LTD (0001015155) (Issuer)

      3/5/24 6:21:11 PM ET
      $CTHR
      Consumer Specialties
      Consumer Discretionary
    • O'Connell Don bought $4,806 worth of shares (13,350 units at $0.36), increasing direct ownership by 3% to 464,464 units (SEC Form 4)

      4 - CHARLES & COLVARD LTD (0001015155) (Issuer)

      3/5/24 9:15:15 AM ET
      $CTHR
      Consumer Specialties
      Consumer Discretionary

    $CTHR
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • O'Connell Don bought $5,550 worth of shares (15,000 units at $0.37) (SEC Form 4)

      4 - CHARLES & COLVARD LTD (0001015155) (Issuer)

      3/7/24 4:15:57 PM ET
      $CTHR
      Consumer Specialties
      Consumer Discretionary
    • Sykes Ollin B bought $7,028 worth of shares (19,000 units at $0.37) (SEC Form 4)

      4 - CHARLES & COLVARD LTD (0001015155) (Issuer)

      3/5/24 6:21:11 PM ET
      $CTHR
      Consumer Specialties
      Consumer Discretionary
    • O'Connell Don bought $4,806 worth of shares (13,350 units at $0.36), increasing direct ownership by 3% to 464,464 units (SEC Form 4)

      4 - CHARLES & COLVARD LTD (0001015155) (Issuer)

      3/5/24 9:15:15 AM ET
      $CTHR
      Consumer Specialties
      Consumer Discretionary

    $CTHR
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Charles & Colvard, Ltd. Announces Delisting from Nasdaq

      RESEARCH TRIANGLE PARK, N.C., April 22, 2025 /PRNewswire/ -- Charles & Colvard, Ltd. ("Charles & Colvard" or the "Company"), announced that the Company received a staff determination letter from the Nasdaq Stock Market, LLC ("Nasdaq"), informing the Company that Nasdaq determined to suspend trading and delist the Company's common stock (the "Common Stock") from Nasdaq because the Company is out of compliance with Listing Rule 5250(c)(1) for failure to timely file its Forms 10-Q for the quarters ended September 30 and December 31, 2024, unless the Company appeals this determination. The Company does not intend to request a hearing to appeal this determination. This decision was based on a car

      4/22/25 4:45:00 PM ET
      $CTHR
      Consumer Specialties
      Consumer Discretionary
    • Charles & Colvard, Ltd. Receives Expected Nasdaq Notice Regarding Delayed Form 10-Q

      RESEARCH TRIANGLE PARK, N.C., March 3, 2025 /PRNewswire/ -- Charles & Colvard, Ltd. ("Charles & Colvard" or the "Company") (NASDAQ:CTHR) today announced that on February 25, 2025, it received an expected notice from the Listing Qualifications Department of the Nasdaq Stock Market LLC ("Nasdaq") stating that the Company continues to not be in compliance with Nasdaq Listing Rule 5250(c)(1) (the "Listing Rule"), as a result of not having timely filed its Quarterly Report on Form 10-Q for the fiscal quarter ended December 31, 2024. Nasdaq previously accepted the Company's plan to regain compliance with the Listing Rule and granted the Company until April 14, 2025 to file its Annual Report on For

      3/3/25 4:45:00 PM ET
      $CTHR
      Consumer Specialties
      Consumer Discretionary
    • Charles & Colvard, Ltd. Receives Interim Award in Wolfspeed Arbitration

      RESEARCH TRIANGLE PARK, N.C., Dec. 11, 2024 /PRNewswire/ -- Charles & Colvard, Ltd. ("Charles & Colvard" or the "Company") (NASDAQ:CTHR) today announced that on December 5, 2024, it received an interim award in its confidential arbitration with Wolfspeed, Inc.  Importantly, the award rejected Wolfspeed's claims to expectation damages of approximately $22.8 million, limiting the Company's damages to just $3.3 million representing approximately $1.3 million for inventory previously purchased and approximately $2.0 million of consigned inventory in the Company's possession, that will now be recorded on the Company's balance sheet as of June 30, 2024 - along with interest, arbitration and limite

      12/11/24 4:10:00 PM ET
      $CTHR
      Consumer Specialties
      Consumer Discretionary

    $CTHR
    Leadership Updates

    Live Leadership Updates

    See more
    • Milestone Scientific Announces CEO Transition, with Chairman Neal Goldman Serving as Interim CEO

      ROSELAND, N.J., Nov. 14, 2024 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, today announced that its Chief Executive Officer Arjan Haverhals will retire from his role as an officer of the company on December 31, 2024. Upon his retirement, Mr. Haverhals will continue to serve as a director on the Board and will provide consulting services to ensure continuity and support through the leadership transition. Mr. Haverhals' retirement, following a distinguished career of over 30 years in the medical device and pharmaceutical industries, reflects his desire to spend more ti

      11/14/24 4:00:00 PM ET
      $CTHR
      $MLSS
      Consumer Specialties
      Consumer Discretionary
      Industrial Specialties
      Health Care
    • Charles & Colvard Joins Russell Microcap® Index

      RESEARCH TRIANGLE PARK, N.C., June 28, 2021 /PRNewswire/ -- Charles & Colvard, Ltd. (NASDAQ:CTHR) (the "Company"), a globally recognized fine jewelry company specializing in lab created moissanite and lab grown diamonds, announced today the Company's addition to the Russell Microcap® Index, effective after the US market opens on June 28, 2021, as a part of the Russell indexes annual reconstitution. Membership in the Russell Microcap® Index, which remains in place for one year, means automatic inclusion in the appropriate growth and value style indexes. FTSE Russell determines

      6/28/21 9:16:00 AM ET
      $CTHR
      Consumer Specialties
      Consumer Discretionary